###begin article-title 0
Elevated Expression of Osteopontin May Be Related to Adipose Tissue Macrophage Accumulation and Liver Steatosis in Morbid Obesity
###end article-title 0
###begin p 1
###xml 37 50 37 50 <email xmlns:xlink="http://www.w3.org/1999/xlink">gual@unice.fr</email>
Corresponding author: Philippe Gual, gual@unice.fr
###end p 1
###begin p 2
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See  for details.
###end p 2
###begin p 3
###xml 0 10 0 10 <bold xmlns:xlink="http://www.w3.org/1999/xlink">OBJECTIVE&#8212;</bold>
###xml 128 134 <span type="species:ncbi:10090">murine</span>
###xml 226 234 <span type="species:ncbi:9606">patients</span>
###xml 239 243 <span type="species:ncbi:10090">mice</span>
OBJECTIVE-Osteopontin (OPN) plays an important role in the development of insulin resistance and liver complications in dietary murine models. We aimed to determine the expression pattern of OPN and its receptor CD44 in obese patients and mice according to insulin resistance and liver steatosis.
###end p 3
###begin p 4
###xml 0 28 0 28 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RESEARCH DESIGN AND METHODS&#8212;</bold>
###xml 87 95 <span type="species:ncbi:9606">patients</span>
###xml 103 107 <span type="species:ncbi:10090">mice</span>
RESEARCH DESIGN AND METHODS-OPN and CD44 expressions were studied in 52 morbidly obese patients and in mice. Cellular studies were performed in HepG2 cells.
###end p 4
###begin p 5
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RESULTS&#8212;</bold>
###xml 119 127 <span type="species:ncbi:9606">patients</span>
###xml 132 136 <span type="species:ncbi:10090">mice</span>
###xml 402 410 <span type="species:ncbi:9606">patients</span>
###xml 607 615 <span type="species:ncbi:9606">patients</span>
RESULTS-Hepatic OPN and CD44 expressions were strongly correlated with liver steatosis and insulin resistance in obese patients and mice. This increased OPN expression could be due to the accumulation of triglycerides, since fat loading in HepG2 promotes OPN expression. In contrast, OPN expression in adipose tissue (AT) was enhanced independently of insulin resistance and hepatic steatosis in obese patients. The elevated OPN expression in AT was paralleled with the AT macrophage infiltration, and both phenomena were reversed after weight loss. The circulating OPN level was slightly elevated in obese patients and was not related to liver steatosis. Further, AT did not appear to secrete OPN. In contrast, bariatric surgery-induced weight loss induced a strong increase in circulating OPN.
###end p 5
###begin p 6
###xml 0 12 0 12 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CONCLUSIONS&#8212;</bold>
###xml 75 83 <span type="species:ncbi:9606">patients</span>
CONCLUSIONS-The modestly elevated circulating OPN levels in morbidly obese patients were not related to liver steatosis and did not appear to result from adipose tissue secretion. In subcutaneous AT, expression of OPN was directly related to macrophage accumulation independently from liver complications. In contrast, hepatic OPN and CD44 expressions were related to insulin resistance and steatosis, suggesting their local implication in the progression of liver injury.
###end p 6
###begin p 7
Published ahead of print at  on 24 October 2008.
###end p 7
###begin p 8
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
###end p 8
###begin p 9
###xml 554 555 554 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r1">1</xref>
###xml 708 709 708 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r2">2</xref>
###xml 710 711 710 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r3">3</xref>
###xml 801 802 801 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r4">4</xref>
###xml 803 804 803 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 901 902 901 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r6">6</xref>
###xml 1046 1047 1046 1047 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r6">6</xref>
###xml 1048 1049 1048 1049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 1219 1220 1219 1220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r6">6</xref>
###xml 1221 1222 1221 1222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 1402 1403 1402 1403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 1404 1406 1404 1406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r11">11</xref>
###xml 1387 1393 <span type="species:ncbi:10090">murine</span>
The incidence of overweight and obesity is rapidly increasing in many Western countries. This epidemic of obesity is associated with the development of type 2 diabetes, hypertension, and nonalcoholic fatty liver disease (NAFLD). These often-ignored hepatic abnormalities extend from simple steatosis to steatohepatitis (nonalcoholic steato-hepatitis [NASH]) and steatofibrosis leading, in some cases, to cirrhosis and hepatocellular carcinoma. NAFLD are frequently observed in the setting of visceral obesity, insulin resistance, and metabolic syndrome (1). Obesity is associated with a low-grade chronic inflammation, as evidenced by increased systemic concentrations of inflammatory markers and cytokines (2,3). The accumulation of macrophages in obese adipose tissue, a key source of inflammation (4,5), provides a causal link between the development of insulin resistance and liver complications (6). The combined elevation of plasma glucose and insulin levels promotes de novo lipid synthesis and impairs lipid oxidation within hepatocytes (6-8). Moreover, insulin resistance of adipose tissue leads to an enhanced delivery of free fatty acids to the liver, contributing to the excessive fatty acids accumulation (6,8). Recently, it has been proposed that osteopontin (OPN), a Th1 cytokine, could play an important role in the development of insulin resistance and NAFLD in dietary murine models (9-11).
###end p 9
###begin p 10
###xml 75 77 75 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 78 80 78 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r13">13</xref>
###xml 167 169 167 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r13">13</xref>
###xml 170 172 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r15">15</xref>
###xml 343 345 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 346 348 346 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r18">18</xref>
###xml 443 444 443 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 445 447 445 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r19">19</xref>
###xml 448 450 448 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r20">20</xref>
###xml 533 534 533 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 535 537 535 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r19">19</xref>
###xml 652 654 652 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r19">19</xref>
###xml 773 775 773 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r21">21</xref>
###xml 776 778 776 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r22">22</xref>
###xml 880 882 880 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r21">21</xref>
###xml 912 913 912 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 1166 1168 1166 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 412 417 <span type="species:ncbi:9606">human</span>
###xml 422 426 <span type="species:ncbi:10090">mice</span>
###xml 509 514 <span type="species:ncbi:9606">human</span>
###xml 519 523 <span type="species:ncbi:10090">mice</span>
###xml 642 650 <span type="species:ncbi:9606">patients</span>
###xml 831 839 <span type="species:ncbi:9606">patients</span>
###xml 1009 1015 <span type="species:ncbi:10090">murine</span>
###xml 1182 1186 <span type="species:ncbi:10090">mice</span>
OPN binds to multiple receptors including the integrin receptors and CD44 (12,13). This cytokine is involved in cell adhesion, chemo-attraction, and immunomodulation (13-15). In particular, OPN is highly secreted by macrophages at inflammation sites where it mediates monocyte adhesion, migration, and differentiation as well as phagocytosis (16-18). Recently, an elevated expression of OPN has been detected in human and mice adipose tissue (9,19,20). Elevated plasma levels of OPN have been associated with human and mice obesity (9,19), and weight loss after low-caloric diets was associated with a reduction of OPN plasma levels in obese patients (19). Furthermore, peroxisome proliferator-activated receptor (PPAR) ligands inhibited the OPN expression in macrophages (21,22), and treatment with bezafibrate in type 2 diabetic patients was correlated with reduced OPN levels (21). Recently, Nomiyama et al. (9) have identified OPN as a link between adipose tissue inflammation and insulin resistance in a murine model of diet-induced obesity. Similarly, OPN can also play an important role in the occurrence of liver complications, as suggested by Sahai et al. (10) in OPN null mice.
###end p 10
###begin p 11
###xml 112 113 112 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 106 110 <span type="species:ncbi:10090">mice</span>
###xml 207 215 <span type="species:ncbi:9606">patients</span>
###xml 319 324 <span type="species:ncbi:9606">human</span>
Based on the evidence that OPN can be considered as a potential actor in obesity-induced complications in mice (9,10), we first analyzed the expression pattern of OPN and its receptor CD44 in morbidly obese patients according to steatosis and insulin resistance. In addition, OPN and CD44 expressions were evaluated in human adipose tissue after a surgically induced weight loss associated with a marked reduction of inflammation and insulin resistance. We then looked for a direct effect of fat loading on OPN expression in a hepatocyte cell line.
###end p 11
###begin title 12
RESEARCH DESIGN AND METHODS
###end title 12
###begin p 13
###xml 155 156 155 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 204 205 204 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 23 27 <span type="species:ncbi:10090">mice</span>
Wild-type C57BL/6 male mice (7-10 weeks of age), obtained from Janvier (Le Genest-St-Isle, France), had free access to water and were fed a standard diet (n = 8) (TD2016, Harlan) or a high-fat diet (HFD, n = 10) containing 36% fat (TD99249, Harlan) for 15 weeks. At the time of death, white epididymal adipose tissue pads and liver samples were removed, immediately frozen in liquid nitrogen, and stored at -80degreesC until used. Serum OPN levels were determined by ELISA (R&D Systems, Lille, France).
###end p 13
###begin title 14
Isolation of hepatocytes and nonparenchymal fraction from liver.
###end title 14
###begin p 15
###xml 86 87 86 87 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 90 91 90 91 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 215 216 215 216 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 451 452 450 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 504 505 503 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 596 597 595 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 786 787 779 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 972 973 959 960 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse livers were perfused first with a HEPES buffer containing 8 g/l NaCl, 33 mg/l Na2HPO4, 200 mg/l KCl, and 2.38 g/l HEPES, pH 7.65, for 2 min at 5 ml/min and then with HEPES buffer supplemented with 1.5 g/l CaCl2 and 25 mg/l liberase (Roche Diagnostics) for 7 min at 5 ml/min. Livers were then carefully removed and minced, and the resultant cell suspension was then filtered (100 mum). Hepatocytes were collected by centrifugation for 5 min at 50g and then on a Percoll density gradient (20 min, 500g) (Sigma). Hepatocytes were then washed in NaCl 0.9%, isolated by centrifugation (5 min, 50g), and frozen at -80degreesC before RNA extraction, as described below. The nonparenchymal cells in the supernatant of first centrifugation were collected by centrifugation for 5 min at 450g and then incubated in NaCl 0.9% buffer supplemented with 0.02% pronase E (Sigma) for 20 min at 37degreesC under gentle agitation. Finally, cells were collected by centrifugation at 450g for 5 min and frozen at -80degreesC before RNA extraction as described below.
###end p 15
###begin title 16
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
Patient population.
###end title 16
###begin p 17
###xml 405 406 401 402 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 810 817 806 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 1227 1229 1223 1225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r23">23</xref>
###xml 1647 1648 1637 1638 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1687 1688 1677 1678 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1734 1735 1724 1725 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1780 1781 1770 1771 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 2053 2055 2043 2045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r24">24</xref>
###xml 2190 2191 2176 2177 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 2233 2234 2217 2218 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 2378 2379 2358 2359 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 2420 2421 2398 2399 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 4 11 <span type="species:ncbi:9606">patient</span>
###xml 46 54 <span type="species:ncbi:9606">patients</span>
###xml 62 70 <span type="species:ncbi:9606">patients</span>
###xml 291 299 <span type="species:ncbi:9606">patients</span>
###xml 502 519 <span type="species:ncbi:11103">hepatitis C virus</span>
###xml 1865 1873 <span type="species:ncbi:9606">patients</span>
###xml 1968 1976 <span type="species:ncbi:9606">patients</span>
###xml 2131 2136 <span type="species:ncbi:9606">women</span>
###xml 2340 2348 <span type="species:ncbi:9606">patients</span>
The patient cohort included 52 morbidly obese patients. These patients were recruited through the Department of Digestive Surgery and Liver Transplantation, where they underwent bariatric surgery for their morbid obesity (Nice and Paris hospitals). Bariatric surgery was indicated for these patients in accordance with the French Guidelines for obesity surgery. Briefly, they had a BMI >/=40 or >/=35 kg/m2 with at least one complication. Exclusion criteria were as follows: presence of hepatitis B or hepatitis C virus infection, excessive alcohol consumption (>20 g/day), or another cause of chronic liver diseases (primary biliary cirrhosis, autoimmune hepatitis, Wilson disease, genetic hemochromatosis, or biliary disease). The clinical and biological characteristics of the study groups are described in Table 1. Before surgery, fasting blood samples were obtained and used to measure alanine amino transferase (ALAT), glucose, insulin, HDL cholesterol, LDL cholesterol, triglycerides, and C-reactive protein (CRP) levels. Serum OPN levels were determined by ELISA (R&D Systems, Lille, France). The degree of insulin resistance was calculated by using the homeostatic model assessment-insulin resistance (HOMA-IR) index (23). Surgical liver biopsies were obtained at the time of bariatric surgery. Part of the biopsy was immediately frozen in liquid nitrogen and stored at -80degreesC until analyzed. The other part was fixed in Bouin solution, paraffin-embedded, sectioned, and stained with hematoxylin-eosin-safran and picro-sirius red. Steatosis was graded from 0-3 based on percent of hepatocytes in the biopsy affected: 0 for none (S0, n = 6); 1 for <30% (S1, mild steatosis, n = 13); 2 for 30-60% (S2, moderate steatosis, n = 9); and 3 for >60% (S3, severe steatosis, n = 24). Subcutaneous and visceral adipose tissue samples were also obtained from 39 patients and frozen until analyzed. The percentage of macrophages in subcutaneous adipose tissue of 19 patients has been evaluated by immunohistochemical analysis as previously described (24). In addition, abdominal subcutaneous adipose tissue was obtained from six women before (age 40.7 +/- 3.2 years; BMI 42.7 +/- 2.0 kg/m2) and 2 years after (BMI 26.0 +/- 1.6 kg/m2) weight loss following bariatric surgery (mean weight loss 44.3 +/- 11.4 kg). Serum was obtained from 25 patients before (BMI 43.9 +/- 5.3 kg/m2) and 1 year after (BMI 27.9 +/- 3.8 kg/m2) weight loss following bariatric surgery (mean weight loss 42.3 +/- 12.3 kg). The second surgery was performed for cosmetic purpose.
###end p 17
###begin title 18
Control subjects.
###end title 18
###begin p 19
###xml 624 625 624 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r3">3</xref>
###xml 626 628 626 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r25">25</xref>
###xml 779 780 775 776 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 962 963 954 955 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 1121 1126 <span type="species:ncbi:9606">Human</span>
Total RNA from six control livers was purchased from Stratagene (La Jolla, CA) (female, 34 years old, normal adjacent tissue to stromal sarcoma), Clontech (Mountain View, CA) (male, 51 years old, sudden death), and Biochain (Hayward, CA) (four males: 24, 26, 28, and 30 years old, sudden deaths). The Stratagene and Biochain companies confirmed that histological findings were completely normal with no evidence of fatty liver disease. No clinical or biological data were available for these individuals, but the absence of an inflammatory process was corroborated by low CRP mRNA expression levels, as previously reported (3,25). Control subcutaneous adipose tissue was obtained from seven lean subjects (five females and two males; age 36.7 +/- 8.4 years; BMI 21.5 +/- 1.9 kg/m2) undergoing lipectomy for cosmetic purposes. Finally, serum was obtained from eight lean healthy volunteers (six females and two males; age 31.6 +/- 2.4 years; BMI 21.2 +/- 0.3 kg/m2) after an overnight fast. All subjects gave their informed consent to participate in this research study according to French legislation regarding Ethic and Human Research (Huriet-Serusclat law, DGS 2003/0395).
###end p 19
###begin title 20
Arteriovenous differences across the adipose tissue.
###end title 20
###begin p 21
###xml 201 202 199 200 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 662 664 660 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r26">26</xref>
###xml 168 171 <span type="species:ncbi:9606">men</span>
###xml 177 182 <span type="species:ncbi:9606">woman</span>
The protocol was approved by the Oxfordshire Clinical Research Ethics Committee, and all subjects gave written informed consent. Five overweight healthy subjects (four men, one woman, BMI 27 +/- 1 kg/m2) were studied after an overnight fast. A 10 cm, a 22-gauge Hydrocath catheter (Becton Dickinson, U.K.) was introduced over a guide wire into a superficial vein on the anterior abdominal wall and threaded toward the groin so that its tip lay just superior to the inguinal ligament. This provided access to the venous drainage from the subcutaneous abdominal adipose tissue, uncontaminated by muscle drainage and with a relatively minor contribution from skin (26). A retrograde cannula was placed in a vein draining the hand, which was warmed in a hot-air box maintained at 60degreesC to obtain arterialized blood. The cannulae were kept patent by a slow infusion of 0.9% (wt/vol) saline. After a resting period of at least 30 min, blood samples were taken simultaneously from the arterialized and adipose tissue venous lines.
###end p 21
###begin title 22
Real-time quantitative PCR analysis.
###end title 22
###begin p 23
###xml 710 711 710 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r3">3</xref>
###xml 712 714 712 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r25">25</xref>
###xml 791 794 791 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OPN</italic>
###xml 827 831 827 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD44</italic>
###xml 864 869 864 869 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD11b</italic>
###xml 887 891 887 891 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD68</italic>
###xml 909 917 909 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNF&#945;</italic>
###xml 935 940 931 936 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F4/80</italic>
###xml 1042 1046 1038 1042 <italic xmlns:xlink="http://www.w3.org/1999/xlink">36B4</italic>
###xml 29 34 <span type="species:ncbi:9606">human</span>
Total RNA was extracted from human and animal tissues using the RNeasy Mini Kit (Qiagen, Contraboeuf, France) and treated with Turbo DNA-free (Applied Biosystems, Contraboeuf, France) following the manufacturer's protocols. The quantity and quality of the isolated RNA were determined using the Agilent 2100 Bioanalyser with RNA 6000 Nano Kit (Agilent Technologies). One microgram of total RNA was reverse-transcribed with a High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA). Real-time quantitative PCR was performed in duplicate for each sample using the ABI PRISM 7500 Fast Real-Time PCR System and FAM dyes (Applied Biosystems, Contraboeuf, France) as previously described (3,25). The TaqMan gene expression assays were purchased from Applied Biosystems: OPN (Hs00167093_m1, Mm00436767_m1); CD44 (Hs00153304_m1; Mm01277163_m1), CD11b (Hs00355885_m1), CD68 (Hs00154355_m1), TNFalpha (Hs00174128_m1), F4/80 (Mm00802530_m1), RPLP0 (large P0 subunit of the acidic ribosomal phosphoprotein, Hs99999902_m1), and 36B4, (Mm99999223_gH).
###end p 23
###begin title 24
OPN immunoblotting.
###end title 24
###begin p 25
###xml 294 296 293 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r27">27</xref>
###xml 29 36 <span type="species:ncbi:9606">patient</span>
Proteins were extracted from patient frozen liver samples using the NucleoSpin RNA/Protein kit (Macherey-Nagel, France) according to the manufacturer's protocol. Proteins (50 mug) were separated by SDS-PAGE using a 10% resolving gel. The Western blotting was performed as previously described (27). The proteins were probed with anti-OPN (AKm2A1) or anti-GAPDH (FL-335) antibodies (Santa Cruz Biotechnology, Santa Cruz, CA) at 1 mug/ml.
###end p 25
###begin title 26
Oleic acid-induced fat loading in HepG2 cells.
###end title 26
###begin p 27
###xml 92 93 92 93 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 210 212 204 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r28">28</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 68 74 <span type="species:ncbi:9913">bovine</span>
Human HepG2 cells were cultured in DMEM supplemented with 10% fetal bovine serum under 5% CO2 at 37degreesC. At 75% confluence, medium was exchanged for new medium with or without 1 mmol/l oleic acid for 24 h (28). Hepatic triglycerides were extracted with a methanol-chloroform mixture and measured using an enzymatic assay (Diagnostic Systems International, Germany). Results were normalized to protein content measured by BCA assay (Pierce, Perbio Science France, Brebieres, France).
###end p 27
###begin title 28
Statistical analysis.
###end title 28
###begin p 29
###xml 333 334 327 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 341 342 335 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Results are expressed as means +/- SE. Statistical significance of differential gene expression between two study groups was determined using the nonparametric Kruskal-Wallis with the DeltaCt of each group. Correlations were analyzed using Spearman's rank correlation test. Other data were statistically analyzed using the Student's t test. P < 0.05 was considered as significant.
###end p 29
###begin title 30
RESULTS
###end title 30
###begin title 31
###xml 60 68 <span type="species:ncbi:9606">patients</span>
OPN and CD44 gene expressions in livers from morbidly obese patients.
###end title 31
###begin p 32
###xml 117 124 117 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 368 369 368 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 362 369 362 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 542 543 538 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 620 621 616 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 614 621 610 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 737 738 733 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 738 739 734 735 <sub xmlns:xlink="http://www.w3.org/1999/xlink">s</sub>
###xml 749 750 745 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 764 765 760 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 765 766 761 762 <sub xmlns:xlink="http://www.w3.org/1999/xlink">s</sub>
###xml 776 777 772 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 857 858 853 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 858 859 854 855 <sub xmlns:xlink="http://www.w3.org/1999/xlink">s</sub>
###xml 869 870 865 866 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 884 885 880 881 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 885 886 881 882 <sub xmlns:xlink="http://www.w3.org/1999/xlink">s</sub>
###xml 896 897 892 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1322 1323 1318 1319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1316 1323 1312 1319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>B</italic></xref>
###xml 1422 1424 1414 1416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 1486 1487 1474 1475 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1521 1522 1509 1510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1542 1543 1530 1531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1663 1664 1647 1648 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1794 1795 1774 1775 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1788 1795 1768 1775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>C</italic></xref>
###xml 85 93 <span type="species:ncbi:9606">patients</span>
###xml 479 487 <span type="species:ncbi:9606">patients</span>
###xml 604 612 <span type="species:ncbi:9606">patients</span>
###xml 1069 1077 <span type="species:ncbi:9606">patients</span>
###xml 1241 1249 <span type="species:ncbi:9606">patients</span>
###xml 1306 1314 <span type="species:ncbi:9606">patients</span>
###xml 1476 1484 <span type="species:ncbi:9606">patients</span>
###xml 1511 1519 <span type="species:ncbi:9606">patients</span>
###xml 1627 1635 <span type="species:ncbi:9606">patients</span>
###xml 1653 1661 <span type="species:ncbi:9606">patients</span>
We studied the OPN and CD44 gene expression in the whole cohort of 52 morbidly obese patients included in the study (Table 1), who were stratified according to the degree of the fat infiltration in liver. We report for the first time that the hepatic OPN and CD44 gene expression was significantly correlated with the grade of hepatic steatosis (from S0 to S3) (Fig. 1A). Noteworthy, when compared with control values, OPN and CD44 gene expressions were markedly increased in S3 patients (9.2 +/- 2.6-fold and 3.5 +/- 0.3-fold, respectively; P < 0.05), whereas CD44 expression was barely increased in S0 patients (Fig. 1A). Furthermore, the hepatic OPN and CD44 gene expression was also significantly correlated with plasma ALAT levels (rs = 0.567, P < 0.001, and rs = 0.549, P < 0.001, respectively) and the insulin resistance as evaluated by the HOMA-IR (rs = 0.474, P = 0.001, and rs = 0.587, P < 0.001, respectively) (data not illustrated). Finally, the OPN protein expression was evaluated by Western blot in total liver lysates obtained from three morbidly obese patients without steatosis (S0) and six with severe steatosis (S3). In accordance with mRNA expression level, the OPN protein level was barely detectable in livers from S0 patients, whereas strong signals were observed in livers from S3 patients (Fig. 1B). Because tumor necrosis factor (TNF)-alpha can stimulate the OPN gene expression in hepatocytes (10), we evaluated the TNF-alpha gene expression of S3 patients (n = 15) compared with S0 patients (n = 6) and controls (n = 5). Interestingly, the gene expression of TNF-alpha was fourfold increased in S3 patients compared with S0 patients (P = 0.004) (data not shown). Moreover, the OPN gene expression was positively correlated with the TNF-alpha gene expression (Fig. 1C). These findings indicate that TNF-alpha and OPN expressions were closely related in vivo.
###end p 32
###begin title 33
Induction of OPN expression in fatty HepG2 cells.
###end title 33
###begin p 34
###xml 415 421 415 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2</xref>
Because we show a correlation between OPN expression and steatosis, we wanted to determine if triglyceride accumulation was sufficient to induce OPN expression in cultured HepG2 cells. Triglyceride accumulation in HepG2 cells was induced by incubation with oleic acid for 24 h. Interestingly, this was associated with a marked increase in the OPN mRNA expression compared with cells cultured in the control medium (Fig. 2).
###end p 34
###begin title 35
###xml 68 76 <span type="species:ncbi:9606">patients</span>
OPN and CD44 gene expressions in adipose tissue from morbidly obese patients.
###end title 35
###begin p 36
###xml 164 165 164 165 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 167 168 167 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 249 250 249 250 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 252 253 252 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 555 556 555 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 549 556 549 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>A</italic></xref>
###xml 861 862 859 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 871 872 869 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 910 911 906 907 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 920 921 916 917 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 961 962 955 956 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1132 1133 1126 1127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1126 1133 1120 1127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>A</italic></xref>
###xml 1258 1259 1250 1251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1268 1269 1260 1261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1307 1308 1297 1298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1317 1318 1307 1308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 100 108 <span type="species:ncbi:9606">patients</span>
###xml 181 189 <span type="species:ncbi:9606">patients</span>
###xml 420 428 <span type="species:ncbi:9606">patients</span>
###xml 1097 1105 <span type="species:ncbi:9606">patients</span>
We next evaluated OPN and CD44 expressions in the adipose tissue that could be obtained in a set of patients without hepatic steatosis and insulin resistance (S0/IR-, n = 9) and in patients with severe hepatic steatosis and insulin resistance (S3/IR+, n = 23) compared with adipose tissue obtained in seven controls subjects. OPN mRNA expression level was significantly increased in the adipose tissue of morbidly obese patients (S0 and S3) compared with lean controls, but different from liver, independently from steatosis and insulin resistance (Fig. 3A). Although comparing mRNA expression from liver, subcutaneous adipose tissue (SCAT) and visceral adipose tissue (VAT) have to be cautiously taken; OPN mRNA expression was much higher in adipose tissues than in liver but did not significantly differ in both adipose tissues (VAT vs. liver: 2.96 +/- 0.54, P < 0.05, n = 16; SCAT vs. liver: 5.02 +/- 1.92, P < 0.05, n = 16; SCAT vs. VAT: 1.66 +/- 0.40, NS, n = 16). There was no difference in CD44 mRNA expression levels in subcutaneous adipose tissue between lean controls and morbidly obese patients (S0 as well as S3) (Fig. 3A). Noteworthy, the CD44 gene expression was much higher in both adipose tissues than in liver (VAT vs. liver: 2.48 +/- 0.37, P < 0.05, n = 16; SCAT vs. liver: 3.20 +/- 0.55, P < 0.05, n = 16).
###end p 36
###begin p 37
###xml 89 90 89 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 279 280 279 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 273 280 273 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>B</italic></xref>
###xml 543 544 543 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 573 574 573 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 587 588 587 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 581 588 581 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>C</italic></xref>
###xml 639 640 639 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 640 641 640 641 <sub xmlns:xlink="http://www.w3.org/1999/xlink">s</sub>
###xml 651 652 651 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 662 663 662 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 67 72 <span type="species:ncbi:10090">mouse</span>
###xml 199 207 <span type="species:ncbi:9606">patients</span>
###xml 533 541 <span type="species:ncbi:9606">patients</span>
Because invalidation of OPN prevents macrophages infiltration into mouse adipose tissue (9), we then compared the OPN gene expression in adipose tissue with that of a macrophages marker, CD68, in 39 patients from the cohort with a wide range of OPN expression. As shown in Fig. 3B, the OPN mRNA expression level was strongly and significantly correlated with the macrophage infiltration, as evaluated by CD68 expression. In accordance with this result, macrophage infiltration was increased in subcutaneous adipose tissue from obese patients (n = 19) versus lean subjects (n = 4) (Fig. 3C) and was correlated with the OPN gene expression (rs = 0.579, P = 0.009, n = 19) (data not shown).
###end p 37
###begin title 38
Effect of weight loss on adipose gene expression.
###end title 38
###begin p 39
###xml 475 476 469 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 469 476 463 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>A</italic></xref>
###xml 707 708 701 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 701 708 695 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>B</italic></xref>
###xml 815 816 809 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 816 817 810 811 <sub xmlns:xlink="http://www.w3.org/1999/xlink">s</sub>
###xml 827 828 821 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 838 839 832 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 839 840 833 834 <sub xmlns:xlink="http://www.w3.org/1999/xlink">s</sub>
###xml 850 851 844 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 996 997 984 985 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1075 1076 1063 1064 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1069 1076 1057 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>B</italic></xref>
###xml 1123 1124 1111 1112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 1124 1125 1112 1113 <sub xmlns:xlink="http://www.w3.org/1999/xlink">s</sub>
###xml 1135 1136 1123 1124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 169 177 <span type="species:ncbi:9606">patients</span>
###xml 253 261 <span type="species:ncbi:9606">patients</span>
###xml 939 947 <span type="species:ncbi:9606">patients</span>
###xml 971 979 <span type="species:ncbi:9606">patients</span>
We then determined if weight loss could modify the gene expression of OPN, CD44, TNF-alpha, and the macrophage marker CD68 in abdominal subcutaneous adipose tissue. Six patients were reevaluated 2 years after their bariatric surgery. As expected, these patients had a marked weight loss (-44.3 +/- 11.4 kg), leading to a notable improvement of systemic inflammation, as evaluated by the circulating levels of CRP and the insulin resistance as evaluated by the HOMA-IR (Fig. 4A). Interestingly, in their adipose tissue, the expression of both OPN and CD44 was drastically decreased and was associated with an important decrease in the macrophage infiltration, as evaluated by the CD68 gene expression (Fig. 4B). Furthermore, the OPN and CD44 mRNA expressions were significantly correlated with CD68 mRNA expression (rs = 0.769, P = 0.003; rs = 0.790, P = 0.002, respectively). In addition, while TNF-alpha expression was increased in obese patients compared with the lean patients (2.69 +/- 0.26, P < 0.05) (data not shown), it was markedly decreased after weight loss (Fig. 4B) and was correlated with OPN mRNA expression (rs = 0.741, P = 0.006) (data not shown). These findings indicate that OPN and CD44 expressions are strongly related to macrophage accumulation in adipose tissue.
###end p 39
###begin title 40
###xml 41 49 <span type="species:ncbi:9606">patients</span>
Circulating OPN levels in morbidly obese patients.
###end title 40
###begin p 41
###xml 77 78 77 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 113 114 113 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 125 126 125 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 136 137 136 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 166 167 166 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 192 193 192 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 186 193 186 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5<italic>A</italic></xref>
###xml 326 327 326 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 374 376 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r19">19</xref>
###xml 470 471 470 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 471 472 471 472 <sub xmlns:xlink="http://www.w3.org/1999/xlink">s</sub>
###xml 482 483 482 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 493 494 493 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 826 827 826 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 820 827 820 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5<italic>B</italic></xref>
###xml 1126 1128 1126 1128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r29">29</xref>
###xml 1129 1131 1129 1131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r31">31</xref>
###xml 1237 1238 1237 1238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1231 1238 1231 1238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5<italic>C</italic></xref>
###xml 55 63 <span type="species:ncbi:9606">patients</span>
###xml 285 293 <span type="species:ncbi:9606">patients</span>
###xml 798 806 <span type="species:ncbi:9606">patients</span>
###xml 1081 1089 <span type="species:ncbi:9606">patients</span>
###xml 1221 1229 <span type="species:ncbi:9606">patients</span>
We then measured OPN serum levels in 52 morbidly obese patients without (S0, n = 6) or with liver steatosis (S1, n = 13; S2, n = 9; S3, n = 24) and control subjects (n = 8). As shown in Fig. 5A, circulating OPN concentrations were modestly but significantly elevated in morbidly obese patients compared with control subjects (n = 8), in agreement with Gomez-Ambrosi et al. (19). However, the circulating OPN levels were not correlated with the grade of liver steatosis (rs = 0.129; P = 0.268, n = 52) (data not shown). The relative contribution of liver and adipose tissue in circulating OPN levels is difficult to estimate. To determine whether circulating OPN could be of adipose tissue origin, we determined the OPN levels in the arterialized and adipose tissue venous plasma in five overweight patients. As shown in Fig. 5B, while adipose tissue enriched the circulating levels of leptin, no significant difference between arterialized and venous adipose tissue samples was observed for OPN. We then investigated if weight loss could modify the circulating levels of OPN in 25 patients. In accordance with recent reports (29-31), the circulating OPN level was 1.8-fold increased 1 year after bariatric surgery in our patients (Fig. 5C).
###end p 41
###begin title 42
###xml 34 38 <span type="species:ncbi:10090">mice</span>
OPN and CD44 expressions in obese mice.
###end title 42
###begin p 43
###xml 622 623 604 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 616 623 598 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f6" ref-type="fig">Fig. 6<italic>A</italic></xref>
###xml 781 782 763 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 775 782 757 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f6" ref-type="fig">Fig. 6<italic>B</italic></xref>
###xml 845 847 827 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob</italic>
###xml 848 850 830 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob</italic>
###xml 858 859 840 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 970 971 950 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1002 1003 980 981 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1060 1061 1036 1037 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1092 1093 1066 1067 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1148 1149 1122 1123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1306 1307 1280 1281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 1307 1308 1281 1282 <sub xmlns:xlink="http://www.w3.org/1999/xlink">s</sub>
###xml 1318 1319 1292 1293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1332 1333 1306 1307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 1333 1334 1307 1308 <sub xmlns:xlink="http://www.w3.org/1999/xlink">s</sub>
###xml 1344 1345 1318 1319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1513 1514 1487 1488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1507 1514 1481 1488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f6" ref-type="fig">Fig. 6<italic>C</italic></xref>
###xml 19 24 <span type="species:ncbi:9606">human</span>
###xml 203 207 <span type="species:ncbi:10090">mice</span>
###xml 852 856 <span type="species:ncbi:10090">mice</span>
###xml 1300 1304 <span type="species:ncbi:10090">mice</span>
To corroborate the human findings and to further explore the potential role of OPN in liver complications of morbid obesity, a series of experiments were performed in various animal models. As expected, mice exposed to HFD exhibited increased weight (45.1 +/- 3.2 vs. 28.2 +/- 1.6 g in low-fat diet-fed controls), increased hepatic triglyceride content (73 +/- 14 vs. 37 +/- 12 mug/mg liver), hyperglycemia (208 +/- 90 vs. 100 +/- 16 mg/dl), and hyperinsulinemia (2.31 +/- 0.63 vs. 0.95 +/- 0.89 mug/l). HFD-induced obesity resulted in increased OPN and CD44 gene expressions in both fatty liver and epididymal WAT (Fig. 6A). Interestingly, the hepatic expressions of OPN and CD44 were also positively correlated with steatosis, as evaluated by hepatic triglyceride content (Fig. 6B). Similar findings were observed in genetic leptin-deficient (ob/ob) mice (n = 5), since OPN and CD44 gene expressions were found to be significantly enhanced in both liver (3.3 +/- 0.3, P < 0.05, and 1.6 +/- 0.1-fold, P < 0.05, respectively) and adipose tissue (23.4 +/- 2.5, P < 0.05, and 5.2 +/- 0.8-fold, P < 0.05, respectively) compared with lean littermates (n = 5). In addition, the adipose tissue expressions of OPN and CD44 were correlated with expression of the macrophage marker F4/80 in HFD-induced obese mice (rs = 0.820, P < 0.01, and rs = 0.843, P < 0.01, respectively). Furthermore, serum OPN levels were also significantly increased, but this increase was moderate, as occurred in liver and adipose tissue (Fig. 6C).
###end p 43
###begin p 44
###xml 120 122 120 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob</italic>
###xml 210 211 210 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 204 211 204 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f6" ref-type="fig">Fig. 6<italic>D</italic></xref>
###xml 645 646 643 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 756 757 752 753 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 125 129 <span type="species:ncbi:10090">mice</span>
We then investigated which liver cell population could be responsible for OPN and CD44 expression. Cells from livers of ob/+ mice were separated into hepatocytes and nonparenchymal fractions. As shown in Fig. 6D, real-time PCR analysis revealed that OPN expression was seven times higher in hepatocytes than in the nonparenchymal fraction. In contrast, CD44 was predominantly expressed in the nonparenchymal fraction. To secure the quality of the separation procedure, albumin and CD11b expression was used as markers of hepatocyte and inflammatory cells, respectively. Albumin was predominantly expressed in the hepatocyte fraction (45 +/- 11, P < 0.05) as well as OPN, whereas CD11b was predominantly expressed in the nonparenchymal fraction (34 +/- 27, P < 0.05) (data not shown) as well as CD44.
###end p 44
###begin title 45
DISCUSSION
###end title 45
###begin p 46
###xml 190 198 <span type="species:ncbi:9606">patients</span>
###xml 754 762 <span type="species:ncbi:9606">patients</span>
We report here that the increased expression of OPN in adipose tissue was associated with the accumulation of macrophages in the adipose tissue. We also describe for the first time that, in patients with severe steatosis and insulin resistance, the hepatic OPN gene expression, as well as the expression of its receptor CD44, were markedly increased and related to the severity of hepatic steatosis. This progressive upregulation of the hepatic OPN gene was significantly associated with liver injury (as evaluated by plasma ALT levels) and hepatic insulin resistance (as evaluated by the HOMA-IR). Local concentrations of OPN in liver and adipose tissue do not appear to affect its systemic levels. Indeed, the modest elevation of systemic OPN in obese patients is not related to liver steatosis or to its marked increase in adipose tissue. Furthermore, weight loss after bariatric surgery was indeed associated with a strong decrease in OPN expression in the adipose tissue, whereas an opposite increase was observed in its systemic level.
###end p 46
###begin p 47
###xml 208 209 208 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 382 383 382 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 384 386 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r17">17</xref>
###xml 387 389 387 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r32">32</xref>
###xml 390 392 390 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r33">33</xref>
###xml 858 859 858 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 1040 1042 1040 1042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r34">34</xref>
###xml 1184 1185 1184 1185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 1030 1038 <span type="species:ncbi:9606">patients</span>
OPN plays an important role in infiltration and accumulation of macrophages in adipose tissue in the early stages of obesity. In vitro chemotaxis assays have revealed that OPN amplified macrophage migration (9). In addition, endogenous OPN in macrophage is required to maintain macrophage function including chemotaxis, an effect mediated by the interaction with its receptor CD44 (9,17,32,33). The increase in the production of such a pro-inflammatory adipokine could activate macrophages already present in the stromal vascular fraction of adipose tissue resulting in an increased production of migratory signal including OPN itself. This could contribute to the over-enrichment of adipose tissue in macrophages. However, the recruitment into adipose tissue of macrophages derived from the circulation in the early stage of obesity is a complex mechanism (5). Other chemokines may play an important role, such as monocyte chemoattractant protein-1 (MCP-1) (produced primarily by adipocytes) with elevated plasma levels in obese patients (34). Indeed, MCP-1 exerts additive effects on chemotaxis in the presence of OPN and amplifies macrophage migration to the same extent than OPN (9).
###end p 47
###begin p 48
###xml 251 252 251 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 253 255 253 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r35">35</xref>
###xml 256 258 256 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r37">37</xref>
###xml 459 460 459 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 461 463 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r35">35</xref>
###xml 464 466 464 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r37">37</xref>
###xml 641 647 <span type="species:ncbi:10090">murine</span>
It has been proposed that the accumulation of macrophages in adipose tissue mediated by OPN, per se, as well as by MCP-1, resulting in an increased macrophage-related inflammatory activity, could be a link between inflammation and insulin resistance (9,35-37). Indeed, the respective invalidation of OPN, MCP-1, or its receptor CCR2 prevents the macrophage accumulation in adipose tissue, inflammation, and insulin resistance mediated by HFD-induced obesity (9,35-37). This appealing hypothesis was further supported by our studies confirming a marked increase in OPN as well as CD44 gene expressions in both liver and adipose tissue in two murine models of obesity. Of particular interest, in the HFD model, OPN and CD44 gene expressions were well correlated with the accumulation of macrophages in adipose tissue.
###end p 48
###begin p 49
###xml 527 529 527 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r38">38</xref>
###xml 530 532 530 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r39">39</xref>
###xml 787 789 787 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r21">21</xref>
###xml 790 792 790 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r22">22</xref>
###xml 842 844 842 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r21">21</xref>
###xml 544 552 <span type="species:ncbi:9606">patients</span>
###xml 832 840 <span type="species:ncbi:9606">patients</span>
Because there is a direct link between OPN-induced macrophage accumulation and insulin resistance, the beneficial effect of weight loss or treatment with anti-inflammatory drugs (PPAR agonists) on inflammation and glucose homeostasis should be associated with a decrease in OPN expression. Indeed, we have shown that weight loss after bariatric surgery resulted in a strong reduction in OPN expression in adipose tissue, together with the marked diminution in the accumulation of macrophages also reported in previous studies (38,39). In these patients, weight loss was also associated with a decreased peripheral inflammation (as evaluated by plasma CRP levels) and an improvement in insulin sensitivity. On the other hand, PPAR agonists can suppress the OPN expression in macrophages (21,22) and decrease plasma levels in treated patients (21).
###end p 49
###begin p 50
###xml 705 707 705 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r29">29</xref>
###xml 708 710 708 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r30">30</xref>
###xml 794 796 794 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r19">19</xref>
###xml 145 153 <span type="species:ncbi:9606">patients</span>
###xml 158 162 <span type="species:ncbi:10090">mice</span>
###xml 282 286 <span type="species:ncbi:10090">mice</span>
###xml 973 981 <span type="species:ncbi:9606">patients</span>
###xml 1169 1177 <span type="species:ncbi:9606">patients</span>
However, the role of circulating OPN in the macrophage infiltration into adipose tissue has not yet been established. We show here that in obese patients and mice, OPN expression was modestly elevated in serum but markedly increased in adipose tissue compared with lean subjects or mice. Whereas weight loss after bariatric surgery resulted in a strong reduction in OPN and CD44 expression and macrophage accumulation in adipose tissue, the circulating levels of OPN were enhanced. In accordance with this result, recent reports have shown that elevated OPN plasma concentration 1 year after bariatric surgery was correlated with markers of bone turnover but not with insulin resistance and inflammation (29,30). On the contrary, diet-induced weight loss could decrease circulating OPN levels (19). Local concentrations of OPN might be different from systemic levels. Furthermore, the tissues or organs contributing to the modestly elevated circulating OPN levels in obese patients were very difficult to estimate. Whereas we show for the first time that systemic OPN levels were not correlated with the grade of liver steatosis and that adipose tissue from overweight patients did not appear to secrete OPN, additional studies are required to know the organ origin of the circulating OPN.
###end p 50
###begin p 51
###xml 105 107 105 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r35">35</xref>
###xml 108 110 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r36">36</xref>
###xml 199 200 199 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r6">6</xref>
###xml 201 202 201 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 417 418 417 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r6">6</xref>
###xml 419 420 419 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 1280 1282 1280 1282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 467 475 <span type="species:ncbi:9606">patients</span>
###xml 480 484 <span type="species:ncbi:10090">mice</span>
###xml 838 846 <span type="species:ncbi:9606">patients</span>
###xml 1234 1238 <span type="species:ncbi:10090">mice</span>
It is currently accepted that insulin resistance can contribute to the development of hepatic steatosis (35,36) through the increased release of free fatty acids secondary to unsuppressed lipolysis (6,8). In addition, the combined elevation of plasma glucose and insulin levels promotes de novo lipid synthesis and impairs lipid oxidation within hepatocytes, further promoting the excessive fatty acids accumulation (6-8). The present data clearly show that in obese patients and mice, the expression of OPN in adipose tissue was positively correlated with macrophage markers. In addition, the hepatic OPN and CD44 gene expressions were significantly increased in the presence of severe steatosis, and this increase was correlated with the severity of steatosis. In parallel, the hepatic OPN protein itself was strongly elevated in obese patients with severe steatosis. Although direct cause-effect relationships cannot be inferred from our data, modification of all parameters could be linked to the severity of steatosis. While the role of OPN in the development of liver complications has not been fully elucidated, invalidation of the OPN gene reduces the plasma ALAT elevation as well as the hepatic inflammation and fibrosis in mice fed a choline-methionine-deficient diet (10).
###end p 51
###begin p 52
###xml 244 246 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r40">40</xref>
###xml 347 352 <span type="species:ncbi:10090">mouse</span>
###xml 436 441 <span type="species:ncbi:9606">human</span>
The cellular origin of the increased hepatic OPN expression has not been yet determined. Although an increased hepatic OPN gene expression has been reported in macrophages, Kupffer cells, and stellate cells in response to carbon tetrachloride (40), we show here that hepatocytes versus the nonhepatocyte cells are the main source of OPN in normal mouse liver. Most interestingly, our in vitro steatosis studies clearly demonstrate that human HepG2 cells cultured in the presence of fatty acids rapidly accumulate triglycerides and, concomitantly, the OPN gene expression is rapidly induced.
###end p 52
###begin p 53
###xml 204 212 <span type="species:ncbi:9606">patients</span>
###xml 916 922 <span type="species:ncbi:9606">humans</span>
###xml 1169 1174 <span type="species:ncbi:9606">human</span>
In summary, we have shown that OPN expression was increased in the adipose tissue early in the course of obesity-induced insulin resistance and before the occurrence of liver steatosis. In morbidly obese patients, OPN could enhance macrophage infiltration and accumulation in the adipose tissue, thus contributing to inflammation and insulin resistance. In the presence of insulin resistance, the accumulation of triglycerides in liver was then associated with an additional upregulation of hepatic OPN and CD44 expression, well related to the severity of steatosis. In addition the hepatic gene expressions of OPN and of its receptor, CD44, were related to the liver injury and hepatic insulin resistance. Our original findings concerning the effects of triglyceride accumulation on hepatoma cells on OPN expression offer some interesting mechanistic explanations for the role of OPN in the development of NAFLD in humans and rodent models. Studies focusing on the behavior of hepatic OPN and CD44 signaling in the progression from normal liver toward steatosis, steatohepatitis, and fibrosis are attractive approaches to acquire more insight into the pathogenesis of human NAFLD.
###end p 53
###begin p 54
This work was supported by grants from the Institut National de la Sante et de la Recherche Medicale (France), ANR-05-PCOD-025-02 PNRHGE to P.G., the University of Nice, the Programme Hospitalier de Recherche Clinique (CHU of Nice and Paris [AOR02076]) the Comite Doyen Jean Lepine (Nice, France), and the French Research Ministery (ACI JC5327 to P.G.). This work is part of the project "Hepatic and adipose tissue and functions in the metabolic syndrome" (HEPADIP, see ), which is supported by the European Commission as an Integrated Project under the 6th Framework Programme (Contract LSHM-CT-2005-018734). A.B. was successively supported by the Programme Hospitalier de Recherche Clinique (CHU of Nice) and the Association pour la Recherche sur le Cancer (France). S.B. was supported by ANR-05-PCOD-025-02. Y.L.M.-B. and P.G. are the recipients of an Interface grant from CHU of Nice. S.L. is the recipient of an Interface grant from AP-HP.
###end p 54
###begin p 55
This work was also supported by charitable donations from ALFEDIAM and AFEF/Schering-Plough (to P.G. and K.C.). No other potential conflicts of interest relevant to this article were reported.
###end p 55
###begin p 56
We thank B. Bailly-Maitre for critical reading of the manuscript.
###end p 56
###begin title 57
REFERENCES
###end title 57
###begin p 58
###xml 120 121 120 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 239 240 239 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 303 304 303 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 351 352 351 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 364 365 364 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 380 381 380 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 578 579 576 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 612 613 610 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 640 641 638 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 667 668 665 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 929 930 927 928 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1021 1022 1011 1012 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1065 1066 1055 1056 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1098 1099 1088 1089 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 110 118 <span type="species:ncbi:9606">patients</span>
###xml 219 227 <span type="species:ncbi:9606">patients</span>
###xml 265 273 <span type="species:ncbi:9606">patients</span>
###xml 333 341 <span type="species:ncbi:9606">patients</span>
###xml 739 747 <span type="species:ncbi:9606">patients</span>
###xml 1047 1055 <span type="species:ncbi:9606">patients</span>
The hepatic OPN and CD44 expression is significantly correlated with the grade of steatosis in morbidly obese patients. A: Hepatic OPN and CD44 mRNA expression levels were analyzed by real-time quantitative PCR in lean patients (controls; n = 6), in morbidly obese patients without liver steatosis (S0; n = 6), and in morbidly obese patients with S1 (n = 13), S2 (n = 9), and S3 (n = 24) steatosis. The gene expression of OPN and CD44 was normalized to the mRNA levels of RPLP0. Results are expressed relative to the expression level in controls and expressed as means +/- SE. *P < 0.05 compared with controls; #P < 0.05 compared with S0; $P < 0.05 compared with S1. B: Total lysates from liver biopsies obtained from three morbidly obese patients without steatosis (S0) and six with severe steatosis (S3) were separated by SDS-PAGE and immunoblotted with anti-OPN or anti-GAPDH antibodies. A representative immunoblot is shown. C: Correlation between OPN and TNF-alpha mRNA expression levels (DeltaCt) in lean subjects (n = 5) and morbidly obese patients without (n = 6) or with severe steatosis (n = 14) was analyzed using Spearman's rank correlation test.
###end p 58
###begin p 59
###xml 390 391 388 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 22 27 <span type="species:ncbi:9606">human</span>
The OPN expression in human HepG2 cells is enhanced after the accumulation of triglycerides. HepG2 cells were incubated without (0) or with 1 mmol/l oleic acid (OA) for 24 h. Intracellular TG levels were determined and normalized to cell protein content. OPN mRNA expression was analyzed by real-time quantitative PCR. Data were expressed as means +/- SE of three independent experiments. *P < 0.05.
###end p 59
###begin p 60
###xml 157 158 157 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 299 300 299 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 384 385 384 385 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 387 388 387 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 474 475 474 475 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 477 478 477 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 583 584 581 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 593 594 591 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 715 716 709 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 826 827 820 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 839 840 833 834 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 857 858 851 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 874 875 868 869 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 892 893 886 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 86 94 <span type="species:ncbi:9606">patients</span>
###xml 279 287 <span type="species:ncbi:9606">patients</span>
###xml 322 330 <span type="species:ncbi:9606">patients</span>
###xml 414 422 <span type="species:ncbi:9606">patients</span>
###xml 847 855 <span type="species:ncbi:9606">patients</span>
###xml 882 890 <span type="species:ncbi:9606">patients</span>
The OPN mRNA expression is increased in subcutaneous adipose tissue of morbidly obese patients and is significantly correlated with macrophage accumulation. A: OPN and CD44 mRNA expression levels were analyzed by real-time quantitative PCR in subcutaneous adipose tissue of lean patients (controls; n = 7), morbidly obese patients without liver steatosis and insulin resistance (S0/IR-; n = 9), and morbidly obese patients with severe steatosis and insulin resistance (S3/IR+; n = 23). Data are presented as relative mRNA normalized to RPLP0 mRNA and are expressed as means +/- SE. *P < 0.05. B: Correlation between OPN and CD68 mRNA expression levels (DeltaCt) was analyzed using Spearman's rank correlation test. C: The percentage of macrophages in subcutaneous adipose tissue has been evaluated in lean subjects (controls; n = 4), S0/IR- obese patients (n = 4), and S3/IR+ obese patients (n = 11).
###end p 60
###begin p 61
###xml 160 161 156 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 366 367 362 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 648 649 638 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 167 175 <span type="species:ncbi:9606">patients</span>
###xml 512 520 <span type="species:ncbi:9606">patients</span>
Weight loss is associated with a strong decrease in the gene expression of OPN, CD44, TNF-alpha, and the macrophage marker CD68 in subcutaneous adipose tissue. A: Six patients were studied before and 2 years after bariatric surgery for BMI, insulin resistance (as evaluated by the HOMA-IR), and systemic inflammation (as evaluated by the circulating levels of CRP). B: OPN, CD44, CD68, and TNF-alpha mRNA expressions were analyzed by real-time quantitative PCR in subcutaneous adipose tissue obtained from these patients before and after weight loss. Data are presented as relative mRNA normalized to RPLP0 mRNA and are expressed as means +/- SE. *P < 0.05.
###end p 61
###begin p 62
###xml 149 150 149 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 189 190 189 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 232 233 232 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 325 326 325 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 415 416 415 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 459 460 457 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 169 177 <span type="species:ncbi:9606">patients</span>
###xml 215 223 <span type="species:ncbi:9606">patients</span>
###xml 315 323 <span type="species:ncbi:9606">patients</span>
###xml 363 371 <span type="species:ncbi:9606">patients</span>
Circulating OPN levels are affected by obesity and weight loss but do not appear to be of adipose tissue origin. OPN levels were evaluated by ELISA (A) in serum of lean patients (controls, n = 8) and morbidly obese patients (obese, n = 52), in the arterial(ized) and adipose tissue venous plasma in five overweight patients (B), and in serum of 25 morbidly obese patients before and 1 year after bariatric surgery (C). Results are expressed as means +/- SE. *P < 0.05.
###end p 62
###begin p 63
###xml 85 86 85 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 238 239 238 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 253 254 253 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 370 371 368 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 539 540 533 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 549 550 543 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 628 629 622 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 670 671 664 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 678 679 672 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 835 837 829 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob</italic>
###xml 918 919 910 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 987 988 979 980 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 79 83 <span type="species:ncbi:10090">mice</span>
###xml 210 214 <span type="species:ncbi:10090">mice</span>
###xml 617 621 <span type="species:ncbi:10090">mice</span>
###xml 840 844 <span type="species:ncbi:10090">mice</span>
OPN and CD44 mRNA expression is increased in liver and adipose tissue of obese mice. A: OPN and CD44 mRNA expressions were analyzed by real-time quantitative PCR in liver and epididymal white adipose tissue of mice fed a normal diet (ND; n = 8) or HFD (n = 10) for 15 weeks. Data are presented as relative mRNA normalized to 36B4 mRNA and are expressed as means +/- SE. B: Correlations between the expression levels of OPN or CD44 mRNA (-DeltaCt) and the hepatic triglyceride content were analyzed using Spearman's rank correlation test. *P < 0.05. C: OPN levels were evaluated by ELISA in serum of HFD-induced obese mice (HFD, n = 6) and serum of lean littermates (ND, n = 6). D: Relative expression of OPN and CD44 was analyzed by real-time quantitative PCR in the isolated hepatocytes versus nonparenchymal fraction in the liver of ob/+ mice. Results are expressed as means +/- SE of three independent experiments. P values were obtained using the nonparametric Kruskal-Wallis test. *P < 0.05.
###end p 63
###begin p 64
###xml 38 46 <span type="species:ncbi:9606">patients</span>
Characteristics of the morbidly obese patients according to grade of hepatic steatosis
###end p 64
###begin p 65
Data are means +/- SE and were compared by using the nonparametric Kruskal-Wallis test.
###end p 65
###begin p 66
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
P < 0.05 compared with S0;
###end p 66
###begin p 67
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
P < 0.05 compared with S1;
###end p 67
###begin p 68
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
P < 0.05 compared with S2.
###end p 68

